Skip to main content

Peer Review reports

From: Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of ‘deep’ product reviews

Original Submission
23 Jun 2017 Submitted Original manuscript
12 Jul 2017 Reviewed Reviewer Report - Larry Sasich
18 Sep 2017 Reviewed Reviewer Report - Tom Jefferson
6 Oct 2017 Author responded Author comments - Shai Mulinari
Resubmission - Version 2
6 Oct 2017 Submitted Manuscript version 2
Publishing
10 Oct 2017 Editorially accepted
9 Nov 2017 Article published 10.1186/s12961-017-0259-8

You can find further information about peer review here.

Back to article page